SCHEMBL3434367

SCHEMBL3434367

NC(=O)c1cc(F)cc(-c2cccc(-c3ncsc3-c3ccnc(Cl)n3)c2)c1F

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 6/20 0.35
CDC7 O00311 6/20 0.35
RORB Q92753 3/20 0.33
SCN9A Q15858 2/20 0.33
RORC P51449 1/20 0.33
CDK2 P24941 3/20 0.32
DBF4 Q9UBU7 2/20 0.32
CCNE1 P24864 2/20 0.32
KMO O15229 2/20 0.32
CYP3A4 P08684 2/20 0.32
CYP1A2 P05177 1/20 0.32
THPO P40225 1/20 0.32
CDK1 P06493 2/20 0.32
GSK3B P49841 2/20 0.32
CDK9 P50750 2/20 0.32
TAOK1 Q7L7X3 2/20 0.32
PLK4 O00444 1/20 0.32
MAPK13 O15264 1/20 0.32
DAPK3 O43293 1/20 0.32
DYRK3 O43781 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3421116 0.85 MAPK14 (0.37) JAK2CDC7SCN9ACDK2DBF4
SCHEMBL5226662 0.77 SLC2A1 (0.41) SCN9AGSK3BMAPK1MAPK8MAPK9
SCHEMBL1640422 0.75 CAMK2D (0.42) CDK2CDK9DYRK3PRKACACDK5
SCHEMBL1642023 0.74 LCLAT1 (0.47) MAPK1LMNA
SCHEMBL31111547 0.73 KMO (0.36) CDC7SCN9ACDK2DBF4CCNE1
SCHEMBL13816258 0.73 RORB (0.33) RORBRORCKMO
SCHEMBL1641900 0.72 MAPT (0.47) JAK2GSK3BTAOK1PRKD3CHEK2
SCHEMBL1641438 0.71 GPBAR1 (0.39) RORBRORC
SCHEMBL3434366 0.71
SCHEMBL31111793 0.71 KMO (0.33) JAK2CDK2KMOCDK1PLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2231625-A1 THIAZOLE AND OXAZOLE KINASE INHIBITORS GlaxoSmithKline LLC (US) 2010-09-29 EP disclosed
WO-2009076140-A1 THIAZOLE AND OXAZOLE KINASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2009-06-18 WO disclosed